Identification by 16S rRNA gene sequencing of Lactobacillus salivarius bacteremic cholecystitis - PubMed (original) (raw)

Case Reports

Identification by 16S rRNA gene sequencing of Lactobacillus salivarius bacteremic cholecystitis

Patrick C Y Woo et al. J Clin Microbiol. 2002 Jan.

Abstract

An anaerobic, nonsporulating, gram-positive bacterium was isolated from blood and bile pus cultures of a 70-year-old man with bacteremic acute cholecystitis. The API 20A system showed that it was 70% Actinomyces naeslundii and 30% Bifidobacterium species, whereas the Vitek ANI system and the ATB ID32A Expression system showed that it was "unidentified." The 16S rRNA gene of the strain was amplified and sequenced. There were 3 base differences between the nucleotide sequence of the isolate and that of Lactobacillus salivarius subsp. salivarius or L. salivarius subsp. salicinius, indicating that the isolate was a strain of L. salivarius. The patient responded to cholecystectomy and a 2-week course of antibiotic treatment. Identification of the organism in the present study was important because the duration of antibiotic therapy would have been entirely different depending on the organism. If the bacterium had been identified as Actinomyces, penicillin for 6 months would have been the regimen of choice. However, it was Lactobacillus, and a 2-week course of antibiotic was sufficient.

PubMed Disclaimer

References

    1. Abramovich, A., J. A. Palmieri, J. J. Kaluza, and C. A. Sabelli. 1974. Initial stages of enamel caries due to Lactobacillus salivarius. Rev. Asoc. Odontol. Argentina 62:141–145. - PubMed
    1. Aiba, Y., N. Suzuki, A. M. Kabir, A. Takagi, and Y. Koga. 1998. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am. J. Gastroenterol. 93:2097–2101. - PubMed
    1. Allison, D., and A. Galloway. 1988. Empyema of the gall-bladder due to Lactobacillus casei. J. Infect. 17:191. - PubMed
    1. Arihara, K., S. Ogihara, T. Mukai, and Y. Kondo. 1996. Salivacin 140, a novel bacteriocin from Lactobacillus salivarius subsp. salicinius T140 active against pathogenic bacteria. Lett. Appl. Microbiol. 22:420–424. - PubMed
    1. Berger, U., P. Lutz, C. Sievers, and F. K. Trefz. 1976. Endocarditis lenta caused by Lactobacillus salivarius subsp. salicinius. Dtsch. Med. Wochenschr. 101:1349–1350. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources